Join hosts Alex Schinasi and Lee Rotenberg on this episode of Unfinished Business as they sit down with Isabelle Kenyon, pioneering entrepreneur and founder of Calibrate. In this candid conversation, Isabelle shares her remarkable journey from investment banking to revolutionizing healthcare following a life-changing injury. Discover how she built a company in the GLP-1 space before most people had heard of Ozempic, and her insights on building category-defining businesses.

Timestamps:

00:53 - Isabelle's background and early career path

01:53 - The skiing accident that changed everything

03:18 - How breaking her back inspired her healthcare mission

04:52 - Developing an entrepreneurial mindset

07:53 - The pharmacy frustration that sparked her business idea

11:21 - The thesis behind direct-to-consumer pharma

14:22 - Pioneering GLP-1 medications before mainstream adoption

18:08 - Understanding Ozempic and metabolic health

24:45 - Raising $100M in just one year for Calibrate

31:12 - The challenges of building without a co-founder

35:37 - Isabelle's next venture: a community platform for GLP-1 users